Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study).

Short and Long-Term Effects of the Angiotensin II Receptor Blocker Irbesartan on Intradialytic Central Hemodynamics: A Randomized Double-Blind Placebo-Controlled One-Year Intervention Trial (the SAFIR Study).

Little is known about the tolerability of antihypertensive drugs during hemodialysis treatment. The present study evaluated the use of the angiotensin II receptor blocker (ARB) irbesartan.Randomized, double-blind, placebo-controlled, one-year intervention trial.Eighty-two hemodialysis patients with...

Full description

Bibliographic Details
Main Authors: Christian Daugaard Peters, Krista Dybtved Kjaergaard, Jens Dam Jensen, Kent Lodberg Christensen, Charlotte Strandhave, Ida Noerager Tietze, Marija Kristina Novosel, Bo Martin Bibby, Bente Jespersen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4452642?pdf=render

Internet

http://europepmc.org/articles/PMC4452642?pdf=render

Similar Items